Weekend Trader Series
September 14, 2025
Open Positions Update
- Please extend the scheduled time-stop date on the Rocket Lab (RKLB) October 17, 2025, 42-strike call to Monday, September 29.
- Close the SolarEdge Technologies (SEDG) October 17, 2025, 32.50-strike call on Monday, September 15. Close the position at a limit price within the range of the current market price when you place the order.
The following is this week's recommendation:Hims & Hers Health (HIMS)Place a limit order to buy the Hims & Hers Health (HIMS) December 19, 2025 50-strike call at a limit price within range of the current market asked price when you place your order. At the close on Friday, September 12, this option was offered at $12.90. HIMS closed at $55.50 on Friday, September 12.Do not attempt to enter this position after Monday's close.Please use the following guidelines to manage the position:- Exit the position if the option is at a 100% gain from your entry price.
- If the option has not reached its target profit by 3:00 p.m. Eastern time on Monday, October 6, close the position.
- If there is a change to the above closeout parameters, we will notify you in your regular Sunday evening communication.
There are strong quantified results when Hims and Hers Health (HIMS) stock crosses above its 50-day moving average, with an average next-month return of 31.8% and an 83%-win rate. HIMS has a nice-looking monthly graph, with pullbacks to its 12-month moving average earlier this month creating supreme buying opportunities. There was also a positive reaction to the company’s expansion of low-testosterone treatments, showing their efforts to expand beyond weight-loss drugs.
Short interest is at a record high, and with a 38% of the stock’s total available float sold short, a short squeeze could create more tailwinds. And despite a 100% year-to-date gain, 10 of the 14 brokerages covering HIMS maintain “hold” or worse ratings, fueling the contrarian potential.
Options-specific support rests at $50, home to peak call open interest (OI). Implied volatilities (IV) are also lower than 85% of daily readings in the past year, making now the time to strike with premium-purchasing.
Our recommended December 50 call has a leverage ratio of 2.9, and will double on a 36.6% rise in the underlying security.
Most Recent Recommendations
The information contained herein is intended solely for the individual subscribers, is not intended for institutional investment organizations, and is not legal to be rebroadcast. Please click here for full disclaimer details.
Limitation on Schaeffer's Investment Research (SIR) liability: SIR liability, whether in contract, tort, negligence, or otherwise, shall be limited in the aggregate to direct and actual damages not to exceed the fees received by SIR from Subscriber. SIR will not be liable for consequential, incidental, punitive, special, exemplary or indirect damages resulting directly or indirectly from the use of or reliance upon any material provided by SIR. Without limitation, SIR shall not be responsible or liable for any loss or damages related to, either directly or indirectly, (1) any decline in market value or loss of any investment; (2) a subscriber's inability to use or any delay in accessing SIR website or any other source of material provided by SIR; (3) any absence of material on SIR website; (4) SIR failure to deliver or delay in delivering any material or (5) any kind of error in transmission of material. SIR and Subscriber acknowledge that, without limitation, the above-enumerated conditions cannot be the probable result of any breach of any agreement between SIR and Subscriber.